Moderna awarded tender for COVID-19 vaccine

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.
Before beginning the discussion of where this company is going, let's set expectations appropriately. Moderna won't be ...
Moderna shares closed up Thursday gaining momentum following recent comments by Oracle Chairman Larry Ellison about the role of artificial intelligence in revolutionizing cancer treatment.
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...
While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...
CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure ...
The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...